Latest Content

RECKGIST Score May Predict Recurrence in Neurofibromatosis Type 1 GISTs

March 12th 2025, 1:00pm

By Spencer Feldman

Article

RECKGIST score may predict recurrence in neurofibromatosis type 1 GISTs, potentially guiding treatment decisions, according to study findings.

Guiding Patients Through Shared Decision-Making in Breast Cancer Care

March 11th 2025, 9:00pm

By Kelly Grosklags

Video

Kelly Grosklags discusses how oncologists can guide patients in shared decision-making while managing expectations following a breast cancer diagnosis.

First Patient Enrolled in Phase 3 Recurrent Prostate Cancer Trial

March 11th 2025, 7:00pm

By Ryan Scott

Article

The first patient has been enrolled in the phase 3 PROSTATE-IQ trial being conducted in men with prostate cancer recurrence following a prostatectomy.

Surviving Life-Threatening Lung Cancer: Lessons Learned

March 11th 2025, 5:00pm

By Sue McCarthy

Article

Life-threatening lung cancer has taught me many valuable lessons and made my new normal so fulfilling.

Vepdegestrant May Reduce Disease Progression in Breast Cancer Subset

March 11th 2025, 4:14pm

By Spencer Feldman

Article

Vepdegestrant improved progression-free survival in patients with estrogen receptor 1 mutations in advanced ER-positive, HER2-negative breast cancer.

JAK Inhibitors Reduce Thromboembolic Risk in Myeloproliferative Neoplasm Therapy

March 11th 2025, 3:38pm

By Alex Biese

Article

JAK inhibitor treatment is associated with a reduction in risk of thromboembolic events for patients with myeloproliferative neoplasms.

Pimitespib Associated With Stable Disease for Some Patients With GIST

March 11th 2025, 1:00pm

By Alex Biese

Article

Treatment with pimitespib was associated with stable disease in two-thirds of patients with advanced gastrointestinal stromal tumors.

Expert Explains Early Signs, Treatment Advances and Care in Multiple Myeloma

March 10th 2025, 9:00pm

By Spencer Feldman

Article

Dr. Joseph Mikhael discusses early signs, treatments and supportive care for multiple myeloma in an interview with CURE.

Lenvima Plus Keytruda With TACE May Improve Liver Cancer Outcomes

March 10th 2025, 7:00pm

By Alex Biese

Article

For patients with unresectable, non-metastatic hepatocellular carcinoma, Lenvima plus Keytruda in combination with TACE improved outcomes.

On Alcohol Addiction for the Patient With Cancer

March 10th 2025, 5:00pm

By Mary Sansone

Article

As a cancer survivor, I overcame alcohol addiction and urge others to seek support, safe detox and sobriety to improve their treatment and recovery.

Understanding the Best Practices Associated With CDK4/6 Therapy in Breast Cancer

March 10th 2025, 4:00pm

By Dr. Sara M. Tolaney

Video

Dr. Sara M. Tolaney discusses breast practices associated with CDK4/6 inhibitors for the treatment of breast cancer.

We Have Come a Long Way

March 10th 2025, 3:00pm

By Dr. Debu Tripathy

Article

CURE magazine's outgoing editor-in-chief, Dr. Debu Tripathy, reflects on 18 years of advances in cancer care, the impact of AI and the evolving future of oncology treatment.

Gleevec Response in GIST May Be Linked to Mutational Profile

March 10th 2025, 1:00pm

By Spencer Feldman

Article

Gleevec response in GIST varies by mutational profile, with KIT-exon-11 mutation linked to better outcomes, emphasizing mutation testing for treatment decisions.

ctDNA May Predict Biliary Tract Cancer Relapse, Recurrence

March 9th 2025, 2:00pm

By Spencer Feldman

Article

Circulating tumor DNA may be a prognostic biomarker for relapse and early recurrence detection in resected early-stage biliary tract cancer.

FDA Approves Biosimilars for Cancer-Related Skeletal Events

March 8th 2025, 7:00pm

By Alex Biese

Article

The FDA has approved Stoboclo and Osenvelt to address skeletal issues faced by patients with cancer.